Chalice Pharmacies Limited - Accounts to registrar (filleted) - small 17.3

Chalice Pharmacies Limited - Accounts to registrar (filleted) - small 17.3


IRIS Accounts Production v17.3.0.1062 03481415 Board of Directors 1.2.16 31.1.17 31.1.17 false true false false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pure034814152016-01-31034814152017-01-31034814152016-02-012017-01-31034814152015-01-31034814152015-02-012016-01-31034814152016-01-3103481415ns15:EnglandWales2016-02-012017-01-3103481415ns14:PoundSterling2016-02-012017-01-3103481415ns10:Director12016-02-012017-01-3103481415ns10:PrivateLimitedCompanyLtd2016-02-012017-01-3103481415ns10:SmallEntities2016-02-012017-01-3103481415ns10:AuditExemptWithAccountantsReport2016-02-012017-01-3103481415ns10:SmallCompaniesRegimeForDirectorsReport2016-02-012017-01-3103481415ns10:SmallCompaniesRegimeForAccounts2016-02-012017-01-3103481415ns10:FullAccounts2016-02-012017-01-310348141512016-02-012017-01-3103481415ns10:Director22016-02-012017-01-3103481415ns10:CompanySecretary12016-02-012017-01-3103481415ns10:RegisteredOffice2016-02-012017-01-3103481415ns5:CurrentFinancialInstruments2017-01-3103481415ns5:CurrentFinancialInstruments2016-01-3103481415ns5:Non-currentFinancialInstruments2017-01-3103481415ns5:Non-currentFinancialInstruments2016-01-3103481415ns5:ShareCapital2017-01-3103481415ns5:ShareCapital2016-01-3103481415ns5:RetainedEarningsAccumulatedLosses2017-01-3103481415ns5:RetainedEarningsAccumulatedLosses2016-01-3103481415ns5:NetGoodwill2016-02-012017-01-3103481415ns5:IntangibleAssetsOtherThanGoodwill2016-02-012017-01-3103481415ns5:LongLeaseholdAssetsns5:LandBuildings2016-02-012017-01-3103481415ns5:FurnitureFittings2016-02-012017-01-3103481415ns5:NetGoodwill2016-01-3103481415ns5:NetGoodwill2017-01-3103481415ns5:NetGoodwill2016-01-3103481415ns5:LongLeaseholdAssetsns5:LandBuildings2016-01-3103481415ns5:FurnitureFittings2016-01-3103481415ns5:LongLeaseholdAssetsns5:LandBuildings2017-01-3103481415ns5:FurnitureFittings2017-01-3103481415ns5:LongLeaseholdAssetsns5:LandBuildings2016-01-3103481415ns5:FurnitureFittings2016-01-3103481415ns5:CostValuation2016-01-3103481415ns5:CurrentFinancialInstrumentsns5:WithinOneYear2017-01-3103481415ns5:CurrentFinancialInstrumentsns5:WithinOneYear2016-01-3103481415ns5:RetainedEarningsAccumulatedLosses2016-01-3103481415ns5:RetainedEarningsAccumulatedLosses2016-02-012017-01-3103481415ns10:Director112016-01-3103481415ns10:Director112015-01-3103481415ns10:Director112016-02-012017-01-3103481415ns10:Director112015-02-012016-01-3103481415ns10:Director112017-01-3103481415ns10:Director112016-01-3103481415ns10:Director222016-01-3103481415ns10:Director222015-01-3103481415ns10:Director222016-02-012017-01-3103481415ns10:Director222015-02-012016-01-3103481415ns10:Director222017-01-3103481415ns10:Director222016-01-31


REGISTERED NUMBER: 03481415 (England and Wales)




UNAUDITED FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 JANUARY 2017

FOR

CHALICE PHARMACIES LIMITED

CHALICE PHARMACIES LIMITED (REGISTERED NUMBER: 03481415)






CONTENTS OF THE FINANCIAL STATEMENTS
for the year ended 31 January 2017




Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 4

Chartered Accountants' Report 8

CHALICE PHARMACIES LIMITED

COMPANY INFORMATION
for the year ended 31 January 2017







DIRECTORS: M S Mann
B S Atwal





SECRETARY: Mrs B K Mann





REGISTERED OFFICE: 1110 Elliott Court
Coventry Business Park
Herald Avenue
Coventry
West Midlands
CV5 6UB





REGISTERED NUMBER: 03481415 (England and Wales)





ACCOUNTANTS: LDP Luckmans
1110 Elliott Court
Coventry Business Park
Herald Avenue
Coventry
West Midlands
CV5 6UB

CHALICE PHARMACIES LIMITED (REGISTERED NUMBER: 03481415)

BALANCE SHEET
31 January 2017

2017 2016
Notes £    £    £    £   
FIXED ASSETS
Intangible assets 4 2,179,692 2,326,049
Tangible assets 5 194,235 216,216
Investments 6 124,011 124,011
2,497,938 2,666,276

CURRENT ASSETS
Stocks 195,198 191,393
Debtors 7 875,894 859,129
Cash at bank and in hand 64,049 98,010
1,135,141 1,148,532
CREDITORS
Amounts falling due within one year 8 1,130,578 1,089,007
NET CURRENT ASSETS 4,563 59,525
TOTAL ASSETS LESS CURRENT
LIABILITIES

2,502,501

2,725,801

CREDITORS
Amounts falling due after more than one
year

9

(2,199,545

)

(2,382,400

)

PROVISIONS FOR LIABILITIES (33,656 ) (37,079 )
NET ASSETS 269,300 306,322

CAPITAL AND RESERVES
Called up share capital 120 120
Retained earnings 10 269,180 306,202
SHAREHOLDERS' FUNDS 269,300 306,322

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 January 2017.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 January 2017 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the
Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at
the end of each financial year and of its profit or loss for each financial year in accordance with the
requirements of Sections 394 and 395 and which otherwise comply with the requirements of the
Companies Act 2006 relating to financial statements, so far as applicable to the company.

CHALICE PHARMACIES LIMITED (REGISTERED NUMBER: 03481415)

BALANCE SHEET - continued
31 January 2017


The financial statements have been prepared and delivered in accordance with the provisions of Part 15 of the Companies Act 2006 relating to small companies.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors on 20 June 2017 and were signed on its
behalf by:





M S Mann - Director


CHALICE PHARMACIES LIMITED (REGISTERED NUMBER: 03481415)

NOTES TO THE FINANCIAL STATEMENTS
for the year ended 31 January 2017

1. STATUTORY INFORMATION

Chalice Pharmacies Limited is a private company, limited by shares , registered in England and Wales.
The company's registered number and registered office address can be found on the Company
Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with the provisions of Section 1A "Small Entities" of Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts,
rebates, value added tax and other sales taxes.

Goodwill
Goodwill, being the amount paid in connection with the acquisition of a business in 1997, is being amortised evenly over its estimated useful life of twenty years.

Intangible assets
Intangible assets are initially measured at cost. After initial recognition, intangible assets are measured
at cost less any accumulated amortisation and any accumulated impairment losses.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Long leasehold - 2% on cost
Fixtures and fittings - 15% on reducing balance

Investments in subsidiaries
Investments in subsidiary undertakings are recognised at cost.

Stocks
Stocks are valued at the lower of cost and net realisable value, after making due allowance for
obsolete and slow moving items.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement,
except to the extent that it relates to items recognised in other comprehensive income or directly in
equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been
enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at
the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods
different from those in which they are recognised in financial statements. Deferred tax is measured
using tax rates and laws that have been enacted or substantively enacted by the year end and that are
expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable
that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

CHALICE PHARMACIES LIMITED (REGISTERED NUMBER: 03481415)

NOTES TO THE FINANCIAL STATEMENTS - continued
for the year ended 31 January 2017

2. ACCOUNTING POLICIES - continued

Hire purchase and leasing commitments
Rentals paid under operating leases are charged to profit or loss on a straight line basis over the
period of the lease.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the
company's pension scheme are charged to profit or loss in the period to which they relate.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 40 .

4. INTANGIBLE FIXED ASSETS
Goodwill
£   
COST
At 1 February 2016
and 31 January 2017 2,927,149
AMORTISATION
At 1 February 2016 601,100
Amortisation for year 146,357
At 31 January 2017 747,457
NET BOOK VALUE
At 31 January 2017 2,179,692
At 31 January 2016 2,326,049

5. TANGIBLE FIXED ASSETS
Fixtures
Long and
leasehold fittings Totals
£    £    £   
COST
At 1 February 2016 57,679 352,340 410,019
Additions - 5,201 5,201
At 31 January 2017 57,679 357,541 415,220
DEPRECIATION
At 1 February 2016 9,778 184,025 193,803
Charge for year 1,154 26,028 27,182
At 31 January 2017 10,932 210,053 220,985
NET BOOK VALUE
At 31 January 2017 46,747 147,488 194,235
At 31 January 2016 47,901 168,315 216,216

CHALICE PHARMACIES LIMITED (REGISTERED NUMBER: 03481415)

NOTES TO THE FINANCIAL STATEMENTS - continued
for the year ended 31 January 2017

6. FIXED ASSET INVESTMENTS
Shares in
group
undertakings
£   
COST
At 1 February 2016
and 31 January 2017 124,011
NET BOOK VALUE
At 31 January 2017 124,011
At 31 January 2016 124,011

7. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2017 2016
£    £   
Trade debtors 697,382 732,495
Other debtors 48,087 46,820
Sundry debtors 100 100
Directors' current accounts 112,762 59,276
Prepayments 17,563 20,438
875,894 859,129

8. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2017 2016
£    £   
Bank loans and overdrafts 157,594 151,594
Trade creditors 735,991 680,775
Amounts owed to group undertakings 124,011 124,011
Tax 85,291 105,364
Social security and other taxes 4,870 3,971
Net wages (487 ) 1,035
Accrued expenses 23,308 22,257
1,130,578 1,089,007

9. CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE
YEAR
2017 2016
£    £   
Bank Loans - More than 1yr 2,199,545 2,382,400

10. RESERVES
Retained
earnings
£   

At 1 February 2016 306,202
Profit for the year 192,978
Dividends (230,000 )
At 31 January 2017 269,180

CHALICE PHARMACIES LIMITED (REGISTERED NUMBER: 03481415)

NOTES TO THE FINANCIAL STATEMENTS - continued
for the year ended 31 January 2017

11. DIRECTORS' ADVANCES, CREDITS AND GUARANTEES

The following advances and credits to directors subsisted during the years ended 31 January 2017 and
31 January 2016:

2017 2016
£    £   
M S Mann
Balance outstanding at start of year 44,476 (8,119 )
Amounts advanced 64,000 52,595
Amounts repaid (5,513 ) -
Amounts written off - -
Amounts waived - -
Balance outstanding at end of year 102,963 44,476

B S Atwal
Balance outstanding at start of year 14,799 (2,701 )
Amounts advanced - 17,500
Amounts repaid (5,000 ) -
Amounts written off - -
Amounts waived - -
Balance outstanding at end of year 9,799 14,799

CHARTERED ACCOUNTANTS' REPORT TO THE BOARD OF DIRECTORS
ON THE UNAUDITED FINANCIAL STATEMENTS OF
CHALICE PHARMACIES LIMITED

The following reproduces the text of the report prepared for the directors in respect of the company's
annual unaudited financial statements. In accordance with the Companies Act 2006, the company is
only required to file a Balance Sheet. Readers are cautioned that the Income Statement and certain
other primary statements and the Report of the Directors are not required to be filed with the
Registrar of Companies.

In order to assist you to fulfil your duties under the Companies Act 2006, we have prepared for your approval
the financial statements of Chalice Pharmacies Limited for the year ended 31 January 2017 which comprise
the Income Statement, Balance Sheet and the related notes from the company's accounting records and from
information and explanations you have given us.

As a practising member firm of the Institute of Chartered Accountants in England and Wales (ICAEW), we are subject to its ethical and other professional requirements which are detailed within the ICAEW's regulations and guidance at http://www.icaew.com/en/membership/regulations-standards-and-guidance.

This report is made solely to the Board of Directors of Chalice Pharmacies Limited, as a body, in accordance with our terms of engagement. Our work has been undertaken solely to prepare for your approval the financial statements of Chalice Pharmacies Limited and state those matters that we have agreed to state to the Board of Directors of Chalice Pharmacies Limited, as a body, in this report in accordance with ICAEW Technical Release 07/16AAF. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than Chalice Pharmacies Limited Board of Directors, as a body, for our work or for this report.

It is your duty to ensure that Chalice Pharmacies Limited has kept adequate accounting records and to prepare statutory financial statements that give a true and fair view of the assets, liabilities, financial position and profit of Chalice Pharmacies Limited. You consider that Chalice Pharmacies Limited is exempt from the statutory audit requirement for the year.

We have not been instructed to carry out an audit or a review of the financial statements of Chalice Pharmacies Limited. For this reason, we have not verified the accuracy or completeness of the accounting records or information and explanations you have given to us and we do not, therefore, express any opinion on the statutory financial statements.






LDP Luckmans
1110 Elliott Court
Coventry Business Park
Herald Avenue
Coventry
West Midlands
CV5 6UB


20 June 2017